MPG.eBooks - Search Results

21

Costs of contact tracing activities aimed at reducing the transmission of measles in Canada

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Contact Tracing / economics...”

Read Now

22

Non-invasive prenatal testing : a review of the cost effectiveness and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cost-Benefit Analysis / economics...”

Read Now

23

Robot-assisted surgery compared with open surgery and laparoscopic surgery : clinical effectiveness and economic analyses

by Ho, Chuong
Published 2011

Canadian Agency for Drugs and Technologies in Health

“... procedures and laparoscopic procedures, followed by a systematic review of economic evaluation studies. We...”

Read Now

24

Pharmacoeconomic review report: Apomorphine (Movapo) (Paladin Labs, Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Dopamine Agonists / economics...”

Read Now

25

Denosumab versus zoledronic acid for adults with osteoporosis : a review of cost-effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Denosumab / economics...”

Read Now

26

Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies

Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Warfarin / economics...”

Read Now

27

Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation : review of Canadian economic studies

Published 2011

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Warfarin / economics...”

Read Now

28

CADTH Canadian Drug Expert Committee recommendation: Tenofovir alafenamide (Vemlidy -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis B.

Published 2018

CADTH

Subjects: “...Antiviral Agents / economics...”

Read Now

29

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Omalizumab / economics...”

Read Now

30

Pharmacoeconomic review report: Brexpiprazole (Rexulti) : (Lundbeck Canada Inc. and Otsuka Canada Pharmaceutical Inc.) : indication: treatment of schizophrenia in adults

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Thiophenes / economics...”

Read Now

31

CADTH Canadian Drug Expert Committee final recommendation: Omalizumab -- resubmission (Xolair -- Novartis Pharmaceuticals Canada Inc.) : indication: asthma

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Omalizumab / economics...”

Read Now

32

Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : systematic review and economic analysis

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Monitoring / economics...”

Read Now

33

Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy : systematic review and economic analysis

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Monitoring / economics...”

Read Now

34

CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive mult...

Published 2018

CADTH

Subjects: “...Immunologic Factors / economics...”

Read Now

35

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ivabradine / economics...”

Read Now

36

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Pharmaceutical Services / economics...”

Read Now

37

CADTH Canadian Drug Expert Committee recommendation: Ivabradine hydrochloride (Lancora -- Servier Canada Inc.) : indication: heart failure, NYHA class II to III.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ivabradine / economics...”

Read Now

38

CADTH Canadian Drug Expert Committee final recommendation: Sapropterin -- resubmission (Kuvan -- BioMarin Pharmaceuticals Canada Inc.) : indication: to reduce blood phenylalanine l...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Insurance, Pharmaceutical Services / economics...”

Read Now

39

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Read Now

40

CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Antibodies, Monoclonal, Humanized / economics...”

Narrow Search